共 50 条
- [21] Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98Breast Cancer Research, 21Kevin H. KenslerMeredith M. ReganYujing J. HengGabrielle M. BakerMichael E. PyleStuart J. SchnittAditi HazraRoswitha KammlerBeat ThürlimannMarco ColleoniGiuseppe VialeMyles BrownRulla M. Tamimi
- [22] Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-upACTA ONCOLOGICA, 2024, 63 : 535 - 541Fohlin, HelenaNordenskjold, AnnaRosell, JohanFerno, MartenFornander, TommyRyden, LisaSkoog, LambertNordenskjold, BoStal, Olle
- [23] Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real worldFRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9Di Cosimo, SerenaLa Rocca, ElianaLjevar, SilvaDe Santis, Maria CarmenBini, MartaCappelletti, VeraValenti, MartaBaili, Paolode Braud, Filippo G.Folli, SecondoScaperrotta, GianfrancoVolpi, ChiaraVingiani, AndreaVernieri, ClaudioVerderio, PaoloMiceli, RosalbaPruneri, Giancarlo
- [24] A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12)ANNALS OF ONCOLOGY, 2010, 21 (02) : 283 - 290Bramwell, V. H. C.Pritchard, K. I.Tu, D.Tonkin, K.Vachhrajani, H.Vandenberg, T. A.Robert, J.Arnold, A.O'Reilly, S. E.Graham, B.Shepherd, L.
- [25] Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98BREAST CANCER RESEARCH, 2019, 21 (1)Kensler, Kevin H.Regan, Meredith M.Heng, Yujing J.Baker, Gabrielle M.Pyle, Michael E.Schnitt, Stuart J.Hazra, AditiKammler, RoswithaThurlimann, BeatColleoni, MarcoViale, GiuseppeBrown, MylesTamimi, Rulla M.
- [26] Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistanceCANCER SCIENCE, 2014, 105 (06) : 675 - 682Takahashi, MaikoHayashida, TetsuOkazaki, HiroshiMiyao, KazuhiroJinno, HiromitsuKitagawa, Yuko
- [27] Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technologyBMC GENOMICS, 2014, 15Fumagalli, DeboraBlanchet-Cohen, AlexisBrown, DavidDesmedt, ChristineGacquer, DavidMichiels, StefanRothe, FrancoiseMajjaj, SamiraSalgado, RobertoLarsimont, DenisIgnatiadis, MichailMaetens, MarionPiccart, MartineDetours, VincentSotiriou, ChristosHaibe-Kains, Benjamin
- [28] Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technologyBMC Genomics, 15Debora FumagalliAlexis Blanchet-CohenDavid BrownChristine DesmedtDavid GacquerStefan MichielsFrançoise RothéSamira MajjajRoberto SalgadoDenis LarsimontMichail IgnatiadisMarion MaetensMartine PiccartVincent DetoursChristos SotiriouBenjamin Haibe-Kains
- [29] The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progressBMC CANCER, 2016, 16Kim, Hyun-AhAhn, Sei HyunNam, Seok JinPark, SehoRo, JungsilIm, Seock-AhJung, Yong SikYoon, Jung HanHur, Min HeeChoi, Yoon JiLee, Soo-JungJeong, JoonCho, Se-HeonKim, Sung YongLee, Min HyukKim, Lee SuMoon, Byung-InKim, Tae HyunPark, ChanheunKim, Sei JoongJung, Sung HooPark, HeungkyuGwak, Geum HeeKang, Sun HeeKim, Jong GinKim, JeryongChoi, Su YunLim, Cheol-WanKim, DoyilYoo, YoungbumSong, Young-JinKang, Yoon-JungJung, Sang SeolShin, Hyuk JaiLee, Kwan JuHan, Se-HwanLee, Eun SookHan, WonshikKim, Hee-JungNoh, Woo Chul
- [30] The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progressBMC Cancer, 16Hyun-Ah KimSei Hyun AhnSeok Jin NamSeho ParkJungsil RoSeock-Ah ImYong Sik JungJung Han YoonMin Hee HurYoon Ji ChoiSoo-Jung LeeJoon JeongSe-Heon ChoSung Yong KimMin Hyuk LeeLee Su KimByung-In MoonTae Hyun KimChanheun ParkSei Joong KimSung Hoo JungHeungkyu ParkGeum Hee GwakSun Hee KangJong Gin KimJeryong KimSu Yun ChoiCheol-Wan LimDoyil KimYoungbum YooYoung-Jin SongYoon-Jung KangSang Seol JungHyuk Jai ShinKwan Ju LeeSe-Hwan HanEun Sook LeeWonshik HanHee-Jung KimWoo Chul Noh